M. Kulyk & Associates’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-333
| Closed | -$295K | – | 113 |
|
|
2024
Q3 | $295K | Buy |
333
+2
| +0.6% | +$1.77K | 0.06% | 91 |
|
|
2024
Q2 | $300K | Sell |
331
-120
| -27% | -$109K | 0.07% | 87 |
|
|
2024
Q1 | $351K | Sell |
451
-2
| -0.4% | -$1.56K | 0.08% | 79 |
|
|
2023
Q4 | $264K | Sell |
453
-5
| -1% | -$2.92K | 0.06% | 91 |
|
|
2023
Q3 | $246K | Buy |
458
+7
| +2% | +$3.76K | 0.07% | 86 |
|
|
2023
Q2 | $212K | Buy |
+451
| New | +$212K | 0.06% | 106 |
|
|
2022
Q4 | – | Sell |
-969
| Closed | -$313K | – | 103 |
|
|
2022
Q3 | $313K | Sell |
969
-316
| -25% | -$102K | 0.11% | 80 |
|
|
2022
Q2 | $417K | Hold |
1,285
| – | – | 0.13% | 71 |
|
|
2022
Q1 | $368K | Buy |
1,285
+25
| +2% | +$7.16K | 0.1% | 77 |
|
|
2021
Q4 | $348K | Buy |
+1,260
| New | +$348K | 0.09% | 69 |
|